Concerns regarding the quality measure for attention-deficit/hyperactivity disorder may limit its usefulness and its ability to promote improvement efforts.
Meredith L. Kilgore, PhD
Advertisement
Articles by Meredith L. Kilgore, PhD
Using longitudinal Medicare claims data, this study quantified the association of the Medicare Part D coverage gap with medication adherence among beneficiaries with chronic obstructive pulmonary disease.
Advertisement
Latest Updated Articles
- An Assessment of the CHIP/Medicaid Quality Measure for ADHD
January 17th 2017
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5